Here are three ways that you can interact with us in Las Vegas:
1) Learn how Drug Channels can help your business.
Drug Channels reaches a large, diverse audience throughout the pharmaceutical and healthcare industries. We have an engaged and growing audience of more than 21,000 readers who regularly open, click, forward, and share our content.
Drug Channels has an engagement rate that is more than twice that of the average media platform.
To discover how you can reach our audience, you can speak personally with my wife and business partner, Paula Fein, M.S.Ed. Paula is Drug Channels Institute’s VP of Business Development. FYI: In the picture, she's on the left. Email her at paula@drugchannelsinstitute.com and she’ll be happy to meet with you.
In the meantime, download the 2018 Drug Channels Media Kit for an overview of the site, our traffic, and opportunities for sponsored posts.
Drug Channels has an engagement rate that is more than twice that of the average media platform.
To discover how you can reach our audience, you can speak personally with my wife and business partner, Paula Fein, M.S.Ed. Paula is Drug Channels Institute’s VP of Business Development. FYI: In the picture, she's on the left. Email her at paula@drugchannelsinstitute.com and she’ll be happy to meet with you.
In the meantime, download the 2018 Drug Channels Media Kit for an overview of the site, our traffic, and opportunities for sponsored posts.
[Click to Download]
2) Join me at the Featured Session.
On Tuesday, May 1, I’ll lead the event’s Featured Session, titled Specialty Pharmacy Industry Outlook: What’s Happened & What’s Ahead. I'll be joined by Doug Long from IQVIA and Lisa Gill from J.P. Morgan Securities. See you in the Encore Ballroom at 9:00 AM!
[Click to Enlarge]
3) Just say hello!
We love meeting and talking with Drug Channels readers, so please introduce yourself. Don’t worry: It will all be off the record. What we discuss in Vegas will stay in Vegas. ;)
See you soon!
P.S. To prep for the Summit, check out Chapter 3 (“Specialty Drugs and Specialty Pharmacies”) of our new 2018 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers.
No comments:
Post a Comment